Product NDC: | 0069-0006 |
Proprietary Name: | Etomidate |
Non Proprietary Name: | Etomidate |
Active Ingredient(s): | 2 mg/mL & nbsp; Etomidate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0006 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078289 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120203 |
Package NDC: | 0069-0006-01 |
Package Description: | 10 VIAL in 1 CARTON (0069-0006-01) > 10 mL in 1 VIAL (0069-0006-02) |
NDC Code | 0069-0006-01 |
Proprietary Name | Etomidate |
Package Description | 10 VIAL in 1 CARTON (0069-0006-01) > 10 mL in 1 VIAL (0069-0006-02) |
Product NDC | 0069-0006 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Etomidate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120203 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
Substance Name | ETOMIDATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |